[1] BROWN SA, SANDHU N, HERRMANN J. Systems biology approaches to adverse drug effects:the example of cardio-oncology[J]. Nat Rev Clin Oncol,2015, 12(12):718-731.
[2] 于彩娜, 范颖, 林庶茹. 芪附汤对阿霉素心脏毒性损伤的保护作用及其抗氧化机制[J]. 中国实验方剂学杂志,2011,17(8):193-196.
[3] 于彩娜, 范颖, 林庶茹. 芪附汤抑制阿霉素心脏毒性损伤大鼠心肌细胞凋亡的研究[J]. 中国实验方剂学杂志,2011,17(15):148-151.
[4] 范颖, 才丽平, 于彩娜, 等. 参附汤、芪附汤、姜附汤对阿霉素心脏毒性损伤大鼠线粒体途径细胞凋亡的影响[J]. 中国实验方剂学杂志,2010,16(8):135-138.
[5] FESSENDEN M. Metabolomics:small molecules, single cells[J]. Nature,2016, 540(7631):153-155.
[6] TAN G, LIAO W, DONG X, et al. Metabonomic profiles delineate the effect of Traditional Chinese Medicine sini decoction on myocardial infarction in rats[J]. PLoS ONE,2012, 7(4):e34157.
[7] SMITH CA, WANT EJ, O'MAILLE G, et al. XCMS:processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification[J]. Anal Chem,2006, 78(3):779-787.
[8] XIA J, WISHART DS. Using metaboanalyst 3.0 for comprehensive metabolomics data analysis[J]. Curr Protoc Bioinformatics,2016, 55(1):14.10.1-14.10.91.
[9] GIKA HG, THEODORIDIS GA, WINGATE JE, et al. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis:application to human urine[J]. J Proteome Res,2007, 6(8):3291-3303.